| Literature DB >> 26054678 |
Rodrigo Pinheiro Araldi1, Thatiana Corrêa de Melo2, Thais Biude Mendes3, Paulo Luiz de Sá Júnior4, Bruno Heidi Nakano Nozima5, Eliana Tiemi Ito6, Rodrigo Franco de Carvalho4, Edislane Barreiros de Souza6, Rita de Cassia Stocco7.
Abstract
Physical, chemical and biological agents can act in the DNA, resulting in mutation involved in cancer. Thus, genotoxic tests are required by regulatory agencies in order to evaluate potential risk of cancer. Among these tests, the comet assay (CA) and micronucleus assay (MNA) are the most commonly used. However, there are different protocols and recommendations already published. This is the first review, after the inclusion of CA in S2R1 guidance and OECD 489, which summarizes the main technical recommendations of both CA and MNA.Entities:
Keywords: Comet assay; Genotoxicity tests; Micronucleus assay; Mutagenesis
Mesh:
Year: 2015 PMID: 26054678 DOI: 10.1016/j.biopha.2015.04.004
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529